Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

Third phase of the Nebulizer should be completed,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TJG Member Profile
Member Level 
Followed By 565
Posts 27,373
Boards Moderated 3
Alias Born 06/20/07
160x600 placeholder
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update PR Newswire (US) - 2/24/2021 9:15:00 AM
Ampio adds new Ampion COVID-19 trial sites Seeking Alpha - 2/23/2021 9:41:24 AM
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion PR Newswire (US) - 2/23/2021 9:15:00 AM
Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference PR Newswire (US) - 2/16/2021 9:15:00 AM
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress PR Newswire (US) - 2/1/2021 9:15:00 AM
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled PR Newswire (US) - 1/14/2021 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:59:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:58:29 PM
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients PR Newswire (US) - 1/4/2021 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/29/2020 4:18:32 PM
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatmen... PR Newswire (US) - 12/29/2020 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:39:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:37:51 PM
Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion PR Newswire (US) - 12/17/2020 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 4:02:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2020 2:25:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2020 2:24:03 PM
Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug,... PR Newswire (US) - 12/10/2020 9:15:00 AM
Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020 PR Newswire (US) - 12/8/2020 9:15:00 AM
Ampio's Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress PR Newswire (US) - 12/2/2020 9:15:00 AM
Ampio Updates Regulatory and Clinical Trial Events PR Newswire (US) - 11/25/2020 9:15:00 AM
Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress PR Newswire (US) - 11/17/2020 9:15:00 AM
Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress PR Newswire (US) - 11/10/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:02:00 PM
TJG Member Level  Wednesday, 11/25/20 06:54:36 AM
Re: rsconcept post# 908
Post # of 1226 
Third phase of the Nebulizer should be completed, its a five day trial then a three day follow up... should get some type of update on that today or first of next week...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences